Deucravacitinib in plaque psoriasis: Four-year safety and efficacy results from the Phase 3 POETYK PSO-1, PSO-2 and long-term extension trials

Hill RC, Grant-Kels JM, Farshchian M. Ethical Considerations in Recommending Patients Avoid Cosmetic Treatments Performed by Non-Physician Providers. J Am Acad Dermatol. 2025 Feb 24:S0190-9622(25)00356-1.[...]

Armstrong AW, Lee K, Yee D, Woodbury M, Zundell M, Zagona-Prizio C, Yousif J, Grant C, Shields A, Chou P, Callis Duffin K, Gottlieb AB,[...]

Olbrich H, Patzelt S, Gaffal E, Kridin K, Curman P, Schmidt E, Ludwig RJ, Kasperkiewicz M. Risk of oesophageal strictures in mucous membrane pemphigoid: Insights[...]